Reports
Global Radiodermatitis Market Growth, Analysis, Forecast: By Product: Topical, Oral, Dressings; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand; Competitive Landscape; 2024-2032
Global Radiodermatitis Market Outlook
The global radiodermatitis market is projected to grow at a CAGR of 3.7% between 2024 and 2032, to attain USD 708.84 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rise in adoption of Radiotherapy to Propel the Market Growth of Radiodermatitis
The development of the market for radiodermatitis is largely driven by the rise in cancer incidence and the increase in the worldwide use of radiotherapy for recovery. In addition, a surge in the geriatric population is also fueling the demand for radiodermatitis. Further, the increased demand for the elimination of radiation therapy-related side effects is projected to deliver attractive business growth opportunities for radiodermatitis industry over the forecast period. In the projected timeframe, North America is predicted to be a significant market for radiodermatitis across the globe due to the increasing prevalence of cancer in the US. Growing demand for radiation therapy is also anticipated to be a significant driving force for the North America industry. In Asia-Pacific, rising public and private investment in cancer treatment and healthcare infrastructure is projected to raise the global market for radiodermatitis during the forecast timeframe.
Radiodermatitis: Market Segmentation
Radiodermatitis is a cutaneous reaction that, during cancer treatment or often after interventional radiology, occurs as one of the side effects of radiotherapy. It is one of the most frequent side effects of radiation therapy for breast, head and neck cancers, lungs, and soft tissue sarcomas used in carcinoma.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
- Topical
- Oral
- Dressings
Topical is divided on the basis of type into corticosteroids, hydrophilic creams, antibiotics, among others. Oral segment is bifurcated, based on type, into corticosteroids and oral analgesics and antibiotics. Dressings is divided on the basis of type into hydrogel and hydrocolloid dressing, no sting barrier film, honey impregnated gauze, and silicone coated, among others.
Based on distribution channel, the market is segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increase in Prevalence of cancer to Augment the Industry Growth of Radiodermatitis
The increase in cancer cases worldwide is expected to prime the radiodermatitis industry for a stable growth trajectory. There are debilitating side effects of radiation therapy, and radiodermatitis is arguably the worse of the lot. According to the National Institute of Health, it is believed to occur in 85% of cancer patients who are treated with radiation. There is a steadily rising demand from cancer patients for successful palliative care solutions in order to offset the extreme effects of radiation. One of the high impact rendering factors for this sector is the growing number of public and private healthcare organisations actively working to promote awareness about radiodermatitis management and treatment. In addition, these organisations issue guidance and recommendations to treat the disease efficiently, which are expected to broaden the growth potential for the industry over the forecast period. The growing number of clinical trials performed to assess the efficacy of a wide variety of treatment products for radiodermatitis treatment is expected to expand the product pipeline of the market.
Key Industry Players in the Global Radiodermatitis Market
The report gives a detailed analysis of the following key players in the global radiodermatitis market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- BMG Pharma S.p.A.
- Stratpharma AG
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Distribution Channel, Region |
| Breakup by Product | Topical, Oral, Dressings |
| Breakup by Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | BMG Pharma S.p.A., Stratpharma AG, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Radiodermatitis Market Analysis
8.1 Key Industry Highlights
8.2 Global Radiodermatitis Historical Market (2018-2023)
8.3 Global Radiodermatitis Market Forecast (2024-2032)
8.4 Global Radiodermatitis Market by Product
8.4.1 Topical
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Corticosteroids
8.4.1.3.1.1 Historical Trend (2018-2023)
8.4.1.3.1.2 Forecast Trend (2024-2032)
8.4.1.3.2 Hydrophilic Creams
8.4.1.3.2.1 Historical Trend (2018-2023)
8.4.1.3.2.2 Forecast Trend (2024-2032)
8.4.1.3.3 Antibiotics
8.4.1.3.3.1 Historical Trend (2018-2023)
8.4.1.3.3.2 Forecast Trend (2024-2032)
8.4.1.3.4 Others
8.4.2 Oral
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.2.3 Breakup by Type
8.4.2.3.1 Corticosteroids
8.4.2.3.1.1 Historical Trend (2018-2023)
8.4.2.3.1.2 Forecast Trend (2024-2032)
8.4.2.3.2 Oral Analgesics and Antibiotics
8.4.2.3.2.1 Historical Trend (2018-2023)
8.4.2.3.2.2 Forecast Trend (2024-2032)
8.4.3 Dressings
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.3.3 Breakup by Type
8.4.3.3.1 Hydrogel and Hydrocolloid Dressing
8.4.3.3.1.1 Historical Trend (2018-2023)
8.4.3.3.1.2 Forecast Trend (2024-2032)
8.4.3.3.2 No Sting Barrier Film
8.4.3.3.2.1 Historical Trend (2018-2023)
8.4.3.3.2.2 Forecast Trend (2024-2032)
8.4.3.3.3 Honey Impregnated Gauze
8.4.3.3.3.1 Historical Trend (2018-2023)
8.4.3.3.3.2 Forecast Trend (2024-2032)
8.4.3.3.4 Silicone Coated
8.4.3.3.4.1 Historical Trend (2018-2023)
8.4.3.3.4.2 Forecast Trend (2024-2032)
8.4.3.3.5 Others
8.5 Global Radiodermatitis Market by Distribution Channel
8.5.1 Hospital Pharmacy
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Retail Pharmacy
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Online Pharmacies
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Others
8.6 Global Radiodermatitis Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Radiodermatitis Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Radiodermatitis Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Radiodermatitis Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Radiodermatitis Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Radiodermatitis Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 BMG Pharma S.p.A.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Stratpharma AG
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Others
17 Key Trends and Developments in the Market
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operation Involved
2 Project Requirement and Cost Analysis
2.1 Land, Location and Site Development
2.2 Construction
2.3 Plant Machinery
2.4 Cost of Raw Material
2.5 Packaging
2.6 Transportation
2.7 Utilities
2.8 Manpower
2.9 Other Capital Investment
List of Key Figures and Tables
1. Global Radiodermatitis Market: Key Industry Highlights, 2018 and 2032
2. Global Radiodermatitis Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Radiodermatitis Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Radiodermatitis Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
5. Global Radiodermatitis Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
6. Global Radiodermatitis Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Radiodermatitis Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Radiodermatitis Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Radiodermatitis Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Radiodermatitis Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Radiodermatitis Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Radiodermatitis Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Radiodermatitis Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Radiodermatitis Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 3.7% between 2024 and 2032.
The industry is being driven by the factors such as the increasing senior population, growing usage of radiotherapy for recovery,rising demand for the eradication of radiation therapy-related side effects, growing number of clinical trials, and rising public and private investment.
The rise in cancer incidences and the expanding number of public and private healthcare organisations actively striving to improve awareness about radiodermatitis management and treatment are the key industry trends propelling the industry forward.
The major regions in the industry are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
The products include topical, oral, and dressings.
Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacies, among others.
The major players in the industry are BMG Pharma S.p.A. and Stratpharma AG, among others.
Analyst Review
The global radiodermatitis market has been driven by the rise in cancer cases. Aided by the increasing senior population and the growing number of clinical trials, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 3.7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The products include topical, oral, and dressings. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacies, among others. The major regional markets for the global radiodermatitis market are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.. The key players in the above market include BMG Pharma S.p.A. and Stratpharma AG, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER